TrialNet is an international network of centers dedicated to conducting research to prevent Type 1 Diabetes and to study intervention therapies for those with newly diagnosed Type 1 Diabetes. The first study in TrialNet is a Natural History Study to learn more about risk factors associated with the development of Type 1 Diabetes.
Candidates
Requirements
Status: Open for Enrollment
How to Participate
This study is administered through the Department of Pediatric Endocrinology at Children’s Hospital of Pittsburgh. For more information, please call 412-692-5210. Visit the TrialNet Web site at www.diabetestrialnet.org.